[{"address1": "149 Fifth Avenue", "address2": "Suite 500", "city": "New York", "state": "NY", "zip": "10010", "country": "United States", "phone": "212 994 8200", "website": "https://www.protagenic.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 1, "companyOfficers": [{"maxAge": 1, "name": "Dr. Garo H. Armen Ph.D.", "age": 70, "title": "Co-Founder & Executive Chairman of the Board", "yearBorn": 1953, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Alexander Kenneth Arrow C.F.A., M.D.", "age": 52, "title": "CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Slee Ph.D.", "age": 73, "title": "Chief Operating Officer", "yearBorn": 1950, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Benjamin Stein M.D., Ph.D.", "age": 72, "title": "Chief Medical Officer & Director", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.593, "open": 0.57, "dayLow": 0.57, "dayHigh": 0.649, "regularMarketPreviousClose": 0.593, "regularMarketOpen": 0.57, "regularMarketDayLow": 0.57, "regularMarketDayHigh": 0.649, "beta": 0.276, "forwardPE": -1.0853448, "volume": 10220, "regularMarketVolume": 10220, "averageVolume": 231385, "averageVolume10days": 31510, "averageDailyVolume10Day": 31510, "marketCap": 2812146, "fiftyTwoWeekLow": 0.5, "fiftyTwoWeekHigh": 1.87, "fiftyDayAverage": 0.67168, "twoHundredDayAverage": 1.00504, "currency": "USD", "enterpriseValue": 1887548, "floatShares": 3259049, "sharesOutstanding": 4467270, "sharesShort": 376933, "sharesShortPriorMonth": 14333, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.0844, "heldPercentInsiders": 0.21674, "heldPercentInstitutions": 0.089490004, "shortRatio": 0.63, "shortPercentOfFloat": 0.1067, "impliedSharesOutstanding": 4467270, "bookValue": 0.177, "priceToBook": 3.556497, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -6403626, "trailingEps": -1.45, "forwardEps": -0.58, "lastSplitFactor": "1:4", "lastSplitDate": 1679529600, "enterpriseToEbitda": -0.315, "52WeekChange": -0.42727274, "SandP52WeekChange": 0.34083736, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PTIX", "underlyingSymbol": "PTIX", "shortName": "Protagenic Therapeutics, Inc.", "longName": "Protagenic Therapeutics, Inc.", "firstTradeDateEpochUtc": 1619530200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c39eb2ce-38b5-3b80-82ab-59608762cc06", "messageBoardId": "finmb_133204458", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.6295, "recommendationMean": 2.0, "recommendationKey": "buy", "totalCash": 924596, "totalCashPerShare": 0.207, "ebitda": -5996464, "quickRatio": 1.371, "currentRatio": 2.029, "returnOnAssets": -0.90172994, "returnOnEquity": -2.0636098, "freeCashflow": -3115366, "operatingCashflow": -5011265, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-03"}]